Archives
- 2018-07
- 2018-10
- 2018-11
- 2019-04
- 2019-05
- 2019-06
- 2019-07
- 2019-08
- 2019-09
- 2019-10
- 2019-11
- 2019-12
- 2020-01
- 2020-02
- 2020-03
- 2020-04
- 2020-05
- 2020-06
- 2020-07
- 2020-08
- 2020-09
- 2020-10
- 2020-11
- 2020-12
- 2021-01
- 2021-02
- 2021-03
- 2021-04
- 2021-05
- 2021-06
- 2021-07
- 2021-08
- 2021-09
- 2021-10
- 2021-11
- 2021-12
- 2022-01
- 2022-02
- 2022-03
- 2022-04
- 2022-05
- 2022-06
- 2022-07
- 2022-08
- 2022-09
- 2022-10
- 2022-11
- 2022-12
- 2023-01
- 2023-02
- 2023-03
- 2023-04
- 2023-05
- 2023-06
- 2023-08
- 2023-09
- 2023-10
- 2023-11
- 2023-12
- 2024-01
- 2024-02
- 2024-03
- 2024-04
- 2024-05
- 2024-06
- 2024-07
- 2024-08
- 2024-09
- 2024-10
- 2024-11
- 2024-12
- 2025-01
- 2025-02
- 2025-03
- 2025-09
-
VER 155008: Decoding Hsp70 Inhibition for Precision Cance...
2025-09-29
Explore the unique biochemical and translational potential of VER 155008, a potent adenosine-derived HSP 70 inhibitor, in disrupting the Hsp70 chaperone pathway and cancer cell survival. This in-depth article offers fresh insights into Hsp70 ATPase inhibition and advanced cancer models, distinct from existing guides.
-
X-press Tag Peptide: Strategic Design for Precision Prote...
2025-09-28
Discover how X-press Tag Peptide empowers advanced protein purification, combining an N-terminal leader peptide, affinity purification via ProBond resin, and Anti-Xpress antibody detection. This article uniquely explores mechanistic integration with cellular signaling studies and best practices for solubility and storage.
-
Sulfo-NHS-SS-Biotin Kit: Revolutionizing Selective Cell S...
2025-09-27
Discover how the Sulfo-NHS-SS-Biotin Kit enables precise, reversible cell surface protein labeling for advanced functional proteomics. This article uniquely explores emerging roles of RNA-binding proteins and glycoRNAs in cell surface biology, providing novel insights beyond standard affinity purification applications.
-
TCEP Hydrochloride: Precision Reducing Agent for Next-Gen...
2025-09-26
Explore how TCEP hydrochloride, a water-soluble reducing agent, is transforming disulfide bond reduction and enabling advanced capture-and-release strategies in bioassay innovation. Learn how its distinct chemistry outperforms traditional reagents and supports ultrasensitive protein analysis.
-
ARCA EGFP mRNA (5-moUTP): Mechanistic Insights and Transl...
2025-09-25
Discover the molecular mechanisms and translational impact of ARCA EGFP mRNA (5-moUTP) as a direct-detection reporter mRNA. This in-depth analysis explores the synergy of Anti-Reverse Cap Analog capping and 5-methoxy-UTP modification, revealing new horizons for fluorescence-based mRNA transfection in mammalian cells.
-
S63845: Next-Generation MCL1 Inhibition for Precision Apo...
2025-09-24
Explore how the potent small molecule MCL1 inhibitor S63845 enables precise activation of mitochondrial apoptosis in hematological cancers. This article uniquely examines its mechanistic selectivity, advanced combinatorial applications, and integration into next-generation apoptosis assays.
-
ABT-199 (Venetoclax): Leveraging Bcl-2 Selective Inhibiti...
2025-09-23
Explore the application of ABT-199 (Venetoclax), a potent Bcl-2 selective inhibitor, in dissecting mitochondrial apoptosis pathways and Bcl-2 mediated cell survival. This article highlights recent mechanistic insights and practical guidance for advanced apoptosis research in hematologic malignancies.
-
EZ Cap™ Firefly Luciferase mRNA: Enhancing Bioluminescent...
2025-09-22
Explore how EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure advances bioluminescent reporter assays, mRNA delivery, and translation efficiency. This article examines the molecular advantages of capped mRNA for enhanced transcription efficiency and its utility in complex in vitro and in vivo research models.
-
Filipin III: Precision Cholesterol Mapping in Liver Disea...
2025-09-19
Explore how Filipin III, a cholesterol-binding fluorescent antibiotic, enables high-resolution visualization of membrane cholesterol in liver disease models. This article details Filipin III’s application in cholesterol detection within membranes and its critical role in unraveling mechanisms of cholesterol homeostasis in metabolic dysfunction-associated steatotic liver disease (MASLD).
-
ARCA EGFP mRNA (5-moUTP): Practical Strategies for Enhanc...
2025-09-18
This article explores the advanced features of ARCA EGFP mRNA (5-moUTP), focusing on its utility as a direct-detection reporter mRNA for fluorescence-based transfection in mammalian cells. Emphasis is placed on the molecular design for innate immune activation suppression and practical storage considerations for ensuring mRNA stability enhancement.
-
Notably we have characterized the mechanism of
2025-03-03
Notably, we have characterized the mechanism of action of ALK in the context of our current understanding of NLRP3 activation [5]. Non-priming macrophages, including BMDMs, exhibit no or minimal activation of NLRP3 in response to ATP. In contrast, LPS priming of macrophages makes them highly suscept
-
In our previous study we
2025-03-03
In our previous study we found that the total activity of aldehyde dehydrogenase in cancer ACK lysis buffer of RCC is at the same level as in normal renal tissue [10]. These findings are similar to our results in serum patients with renal cancer. There is no significant difference between ALDH acti
-
With one exception all receptors for dopamine DA serotonin h
2025-03-03
With one exception, all receptors for dopamine (DA), serotonin (5-hydroxytryptamine, 5-HT), and norepinephrine are metabotropic receptors. The five metabotropic DA receptors (D1–D5) in the CNS are involved in motivation, pleasure, cognition, learning, memory, fine motor control, and modulate neuroen
-
br There is evidence to suggest that GMF activities are
2025-03-03
There is evidence to suggest that GMF activities are regulated in vivo by post-translational modification. indeed, there is strong precedent for ADF-homology family proteins being regulated in this manner. Cofilin is inhibited by phosphorylation of a serine residue at its N terminus. This residue
-
Additionally in a previous transgenic model
2025-03-03
Additionally, in a previous transgenic model with autotaxin under the control of the MMTV-LTR promoter, aberrant expression of human autotaxin caused late-onset, metastatic breast cancer [5]. The AT-ATX transgenic model is analogous to the previous one because ∼30% of all spontaneous tumors appeared